{"id":51471,"date":"2019-06-04T17:00:50","date_gmt":"2019-06-04T22:00:50","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=51471"},"modified":"2022-11-30T09:42:54","modified_gmt":"2022-11-30T14:42:54","slug":"growfl-announces-national-drug-screening-is-th-annual-florida-companies-to-watch-finalist","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/growfl-announces-national-drug-screening-is-th-annual-florida-companies-to-watch-finalist\/","title":{"rendered":"GrowFL Announces National Drug Screening is 9th Annual Florida Companies to Watch Finalist"},"content":{"rendered":"\n<p>(Melbourne, Fla.)&nbsp; National Drug Screening, Inc. was among the first round of the 2019 Florida Companies to Watch finalists recently announced by GrowFL.&nbsp; The awards event &#8211; now in its ninth year &#8211; honors 50 select second-stage companies from throughout the state for developing valuable products and services, creating quality jobs, enriching communities, and broadening new industries throughout Florida. Chosen from 224 growing second-stage participants from throughout, Florida, this year\u2019s applicants had a total revenue of $596 million and over 3,000 employees.<\/p>\n\n\n\n<p><strong>&#8220;This is a great honor to be selected as a Florida Companies to Watch Finalist. Our amazing<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Melbourne, Fla.)&nbsp; National Drug Screening, Inc. was among the first round of the 2019 Florida Companies to Watch finalists recently announced by GrowFL.&nbsp; The awards event &#8211; now in its ninth year &#8211; honors 50 select second-stage companies from throughout the state for developing valuable products and services, creating quality jobs, enriching communities, and broadening [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":53871,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"50858,54976,50870,50935,51522,51391","_relevanssi_noindex_reason":"","footnotes":""},"categories":[132],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51471"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=51471"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51471\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/53871"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=51471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=51471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=51471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}